Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II trial.

Details

Language :

English

ISSN :

09395555

Volume :

91

Issue :

2

Database :

Complementary Index

Journal :

Annals of Hematology

Publication Type :

Academic Journal

Accession number :

104382546